A detailed history of Commonwealth Equity Services, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 66,408 shares of CRSP stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,408
Previous 61,559 7.88%
Holding current value
$2.72 Million
Previous $3.33 Million 6.17%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$44.62 - $62.75 $216,362 - $304,274
4,849 Added 7.88%
66,408 $3.12 Million
Q2 2024

Jul 31, 2024

BUY
$51.17 - $68.18 $386,845 - $515,440
7,560 Added 14.0%
61,559 $3.33 Million
Q1 2024

Apr 29, 2024

BUY
$60.67 - $89.12 $447,926 - $657,972
7,383 Added 15.84%
53,999 $3.68 Million
Q4 2023

Feb 06, 2024

BUY
$38.62 - $72.18 $254,621 - $475,882
6,593 Added 16.47%
46,616 $2.92 Million
Q3 2023

Oct 23, 2023

SELL
$45.39 - $59.0 $47,114 - $61,242
-1,038 Reduced 2.53%
40,023 $1.82 Million
Q2 2023

Aug 10, 2023

BUY
$43.47 - $67.77 $31,298 - $48,794
720 Added 1.78%
41,061 $2.31 Million
Q1 2023

May 11, 2023

SELL
$41.0 - $56.12 $440,463 - $602,897
-10,743 Reduced 21.03%
40,341 $1.82 Million
Q4 2022

Feb 07, 2023

SELL
$39.19 - $65.67 $2.2 Million - $3.69 Million
-56,244 Reduced 52.4%
51,084 $2.08 Million
Q3 2022

Nov 14, 2022

BUY
$61.1 - $83.78 $3.72 Million - $5.1 Million
60,830 Added 130.82%
107,328 $7.01 Million
Q2 2022

Jul 19, 2022

BUY
$43.23 - $73.83 $146,290 - $249,840
3,384 Added 7.85%
46,498 $2.83 Million
Q1 2022

May 04, 2022

BUY
$53.19 - $79.24 $411,211 - $612,604
7,731 Added 21.85%
43,114 $2.71 Million
Q4 2021

Jan 31, 2022

SELL
$70.09 - $111.29 $210,970 - $334,982
-3,010 Reduced 7.84%
35,383 $2.68 Million
Q3 2021

Oct 29, 2021

BUY
$110.2 - $156.64 $372,255 - $529,129
3,378 Added 9.65%
38,393 $4.3 Million
Q2 2021

Aug 11, 2021

BUY
$100.84 - $161.89 $491,595 - $789,213
4,875 Added 16.17%
35,015 $5.67 Million
Q1 2021

May 04, 2021

BUY
$110.72 - $210.04 $251,888 - $477,841
2,275 Added 8.16%
30,140 $3.67 Million
Q4 2020

Feb 11, 2021

BUY
$79.67 - $173.23 $250,721 - $545,154
3,147 Added 12.73%
27,865 $4.27 Million
Q3 2020

Nov 05, 2020

SELL
$78.5 - $100.64 $20,174 - $25,864
-257 Reduced 1.03%
24,718 $2.07 Million
Q2 2020

Aug 12, 2020

SELL
$38.5 - $76.05 $733,964 - $1.45 Million
-19,064 Reduced 43.29%
24,975 $1.84 Million
Q1 2020

May 11, 2020

BUY
$33.68 - $62.53 $454,915 - $844,592
13,507 Added 44.24%
44,039 $1.87 Million
Q4 2019

Feb 05, 2020

BUY
$36.68 - $73.13 $452,301 - $901,766
12,331 Added 67.75%
30,532 $1.86 Million
Q3 2019

Oct 30, 2019

BUY
$40.99 - $52.56 $15,822 - $20,288
386 Added 2.17%
18,201 $746,000
Q2 2019

Jul 19, 2019

BUY
$35.45 - $48.2 $34,953 - $47,525
986 Added 5.86%
17,815 $839,000
Q1 2019

May 13, 2019

BUY
$28.02 - $40.87 $114,545 - $167,076
4,088 Added 32.09%
16,829 $601,000
Q4 2018

Feb 11, 2019

SELL
$22.73 - $42.34 $13,115 - $24,430
-577 Reduced 4.33%
12,741 $364,000
Q3 2018

Nov 06, 2018

BUY
$44.35 - $65.71 $41,910 - $62,095
945 Added 7.64%
13,318 $590,000
Q2 2018

Jul 31, 2018

BUY
$42.62 - $73.59 $281,292 - $485,694
6,600 Added 114.33%
12,373 $727,000
Q1 2018

May 14, 2018

BUY
$23.52 - $58.17 $135,780 - $335,815
5,773 New
5,773 $263,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.19B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.